RUNX1 (Ab-435) AntibodyСпецификацияОбъем | 100 мкл | Синонимы | Acute myeloid leukemia 1 protein, CBF-alpha 2, CBFA2, Core-binding factor, alpha 2 subunit | Клональность | Polyclonal Antibody | Организм | Human | uniprot | Q01196 | Иммуноген | Synthesized non-phosphopeptide derived from human AML1 around the phosphorylation site of serine 435 (S-N-S(p)-P-T). | Источник | Rabbit | Видовая специфичность | Human, Mouse | Применение | ELISA, WB,WB:1:500-1:3000 | Примечание | CBF binds to the core site, 5'-PYGPYGGT-3', of a number of enhancers and promoters, including murine leukemia virus, polyomavirus enhancer, T-cell receptor enhancers, LCK, IL-3 and GM-CSF promoters. The alpha subunit binds DNA and appears to have a role in the development of normal hematopoiesis. Isoform AML-1L interferes with the transactivation activity of RUNX1. Acts synergistically with ELF4 to transactivate the IL-3 promoter and with ELF2 to transactivate the mouse BLK promoter. Inhibits KAT6B-dependent transcriptional activation.<br/><br/>Miyoshi H., Proc. Natl. Acad. Sci. U.S.A. 88:10431-10434(1991).<br/>Sacchi N., Genes Chromosomes Cancer 11:226-236(1994).<br/>Nucifora G., Blood 81:2728-2734(1993).<br/> | Клональность1 | Polyclonal | Изотип | IgG | Коньюгат | Non-conjugated | Буффер | Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. | Форма | liquid | Хранение | Upon receipt, store at -20°C or -80°C. Avoid repeated freeze. | Метод очистки | The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. | Области исследований | Epigenetics and Nuclear Signaling,Neuroscience,Cancer,Developmental biology,Stem cells | Ссылка на страницу на сайте производителя | ссылка | Western blot analysis of extracts from HepG2 cells, treated with PMA (125ng/ml, 30mins), using AML1 (Ab-435) antibody.
![](http://www.cusabio.cn/images/cb/CSB-PA132524-WB-1.jpg) | Western blot analysis of extracts from 293 cells (Lane 2) and Hela cells (Lane 3), using AML1 (Ab-435) antiobdy. The lane on the left is treated with synthesized peptide.
![](http://www.cusabio.cn/images/cb/CSB-PA132524-WB-2.jpg) | | |
Информация для заказа |